These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 28292399)
41. Pharmacotherapy in pediatric obesity: current evidence and landscape. Singhal V; Sella AC; Malhotra S Curr Opin Endocrinol Diabetes Obes; 2021 Feb; 28(1):55-63. PubMed ID: 33186194 [TBL] [Abstract][Full Text] [Related]
42. Current pharmacotherapy for obesity: extrapolation of clinical trials data to practice. Gadde KM Expert Opin Pharmacother; 2014 Apr; 15(6):809-22. PubMed ID: 24548209 [TBL] [Abstract][Full Text] [Related]
44. Current Perspectives on Long-term Obesity Pharmacotherapy. Wharton S Can J Diabetes; 2016 Apr; 40(2):184-91. PubMed ID: 26507402 [TBL] [Abstract][Full Text] [Related]
45. An update on pharmacotherapeutic strategies for obesity. Tchang BG; Tarazi MS; Aras M; Shukla AP Expert Opin Pharmacother; 2021 Jul; 22(10):1305-1318. PubMed ID: 33599159 [TBL] [Abstract][Full Text] [Related]
46. Drug therapy for obesity. Dickerson LM; Carek PJ Am Fam Physician; 2000 Apr; 61(7):2131-8, 2143. PubMed ID: 10779254 [TBL] [Abstract][Full Text] [Related]
47. Pharmacotherapy for weight loss: the cardiovascular effects of the old and new agents. Walter CP; Bleske BE; Dorsch MP J Clin Pharm Ther; 2014 Oct; 39(5):475-84. PubMed ID: 24924286 [TBL] [Abstract][Full Text] [Related]
48. Novel strategy for the use of leptin for obesity therapy. Tam CS; Lecoultre V; Ravussin E Expert Opin Biol Ther; 2011 Dec; 11(12):1677-85. PubMed ID: 21910668 [TBL] [Abstract][Full Text] [Related]
49. Medications for weight reduction. Bray GA Med Clin North Am; 2011 Sep; 95(5):989-1008. PubMed ID: 21855704 [TBL] [Abstract][Full Text] [Related]
50. Anti-obesity drugs: a review about their effects and their safety. Derosa G; Maffioli P Expert Opin Drug Saf; 2012 May; 11(3):459-71. PubMed ID: 22439841 [TBL] [Abstract][Full Text] [Related]
51. Well-being of obese individuals: therapeutic perspectives. Chaput JP; Tremblay A Future Med Chem; 2010 Dec; 2(12):1729-33. PubMed ID: 21428796 [TBL] [Abstract][Full Text] [Related]
53. Increasing prevalence of obesity and clustered cardiometabolic risk: can treatment of the underlying cause reverse the trends? Ballantyne CM Crit Pathw Cardiol; 2007 Jun; 6(2):41-5. PubMed ID: 17667863 [TBL] [Abstract][Full Text] [Related]
54. [Novel anti-obesity drugs]. Tripp B; Ludvik B Acta Med Austriaca; 2004; 31(4):133-8. PubMed ID: 15732249 [TBL] [Abstract][Full Text] [Related]
55. New molecular targets in the pathophysiology of obesity and available treatment options under investigation. Valsamakis G; Lois K; Kumar S; Mastorakos G Clin Obes; 2014 Aug; 4(4):209-19. PubMed ID: 25826792 [TBL] [Abstract][Full Text] [Related]
56. Approaches to obesity management. Sweeting AN; Caterson ID Intern Med J; 2017 Jul; 47(7):734-739. PubMed ID: 28677316 [TBL] [Abstract][Full Text] [Related]